The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
The FDA’s Vaccines and Related Biological Products Advisory Committee had been scheduled to meet Thursday to weigh in on the composition of the flu shots, but that session was canceled without explanation in late February.
Instead, experts from within the FDA, the US Centers for Disease Control and Prevention and the US Department of efense gathered Thursday to go over surveillance data from the US and around the world about flu viruses that are currently circulating.
The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza
A and one of influenza B.
...
